ClinicalTrials.Veeva

Menu

Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease

N

New Aera, Inc

Status

Unknown

Conditions

Chronic Obstructive Lung Disease
Interstitial Lung Disease

Treatments

Device: Tidal Assist Ventilator System
Device: Nasal Cannula Oxygen

Study type

Interventional

Funder types

Industry

Identifiers

NCT02278107
JM-001-2014

Details and patient eligibility

About

A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.

Full description

An open-label, randomized, controlled, crossover study in patients with severe chronic lung disease to evaluate exercise tolerance compared to standard nasal cannula oxygen therapy.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult male or female (> 18 years of age) with a diagnosis of severe-to-very severe chronic lung disease
  • Participates in a qualified pulmonary rehabilitation program
  • Requires constant flow oxygen of ≥ 2 LPM (liters per minute) during exercise
  • Able and willing to sign the informed consent
  • Ability to be fitted with the test nasal mask and to use the test ventilator system

Exclusion criteria

  • Requires > 5LPM of constant flow to maintain SpO2> 90% during exercise
  • Reports having serious epistaxis within the last 14 days prior to enrollment
  • Currently enrolled in another clinical study or has participated within 30 days of enrollment
  • Has any condition or abnormality that in the opinion of the Investigators may compromise the participant's safety or the quality of the study data

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Tidal Assist Ventilator System
Experimental group
Description:
Lightweight, portable, positive pressure ventilator system with proprietary nasal interface. Ventilator is powered by compressed oxygen delivered by cylinder, concentrator, or wall source.
Treatment:
Device: Tidal Assist Ventilator System
Nasal Cannula Oxygen
Active Comparator group
Description:
Nasal Cannula Oxygen Standard nasal cannula oxygen at 2-5 liters per minute (LPM) based on patient requirement. Oxygen sources includes cylinder, concentrator, or wall source.
Treatment:
Device: Nasal Cannula Oxygen

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems